SHR-110008, formerly known as Felotaxel, is a microtubule inhibitor potentially for the treatment of cancer. References: Ding Y, Liu W, Lu C, Yang J, Zhu Y, Song Y, Ma Z, Yang L, Jia Y, Wen A. Preclinical pharmacokinetic analysis of felotaxel (SHR110008), a novel derivative of docetaxel, in rats and its protein binding ability in vitro. Biomed Pharmacother. 2012 Mar;66(2):98-102. doi: 10.1016/j.biopha.2011.11.012. PubMed PMID: 22264880.

纯度：≥98%

CAS：944154-59-0